Ligand Pharmaceuticals Inc (NASDAQ:LGND)

77.30
Delayed Data
As of 12:36pm ET
 +0.19 / +0.25%
Today’s Change
41.99
Today|||52-Week Range
79.61
+45.27%
Year-to-Date

Today’s Trading

Previous close77.11
Today’s open77.63
Day’s range76.30 - 78.84
Volume262,817
Average volume (3 months)347,219
Market cap$1.5B
Dividend yield--
Data as of 12:36pm ET, 04/01/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+42.60%
Earnings growth (next 5 years)+38.40%
Revenue growth (last year)+31.78%
P/E ratio138.0
Price/Sales16.83
Price/Book57.35

Competitors

 Today’s
change
Today’s
% change
CMRXChimerix Inc-0.59-1.57%
NLNKNewLink Genetics Cor...-2.46-4.50%
ACORAcorda Therapeutics ...-0.27-0.81%
USNAUSANA Health Science...+2.61+2.35%
Data as of 12:51pm ET, 04/01/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.27
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President, Chief Operating Officer &
Director
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account